3.08

1.65% 0.05

Sight Sciences Inc (SGHT)

Overview News Price History Option Chain Financials Why SGHT Down? Discussions Forecast

Sight Sciences Inc stock is traded at $3.08, with a volume of 233.67K. It is up +1.65% in the last 24 hours and up +31.06% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Previous Close:

$3.03

Open:

$3.38

24h Volume:

233.67K

Relative Volume:

1.00

Market Cap:

$157.67M

Revenue:

$81.06M

Net Income/Loss:

$-55.55M

P/E Ratio:

-2.7018

EPS:

-1.14

Net Cash Flow:

$-47.98M

1W Performance:

+0.98%

1M Performance:

+31.06%

6M Performance:

-27.19%

1Y Performance:

-44.60%

1-Day Range:

$2.94

$3.38

1-Week Range:

$2.74

$3.38

52-Week Range:

$2.03

$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name

Sight Sciences Inc

Sector

Healthcare (1153)

Industry

Medical Devices (157)

Phone

(415) 889-0550

Address

4040 CAMPBELL AVE,, MENLO PARK

Employee

216

Twitter

Next Earnings Date

2025-03-05

Latest SEC Filings

SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGHT Sight Sciences Inc	3.08	157.67M	81.06M	-55.55M	-47.98M	-1.14
ABT Abbott Laboratories	133.24	231.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.86	155.24B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	380.92	144.54B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	83.48	108.82B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.68	44.31B	5.54B	4.18B	623.10M	7.00

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-06-24	Initiated	UBS	Buy
Nov-04-24	Downgrade	Lake Street	Buy → Hold
Aug-21-24	Initiated	Lake Street	Buy
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Jan-06-23	Upgrade	Stifel	Hold → Buy
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Sight Sciences Inc Stock (SGHT) Latest News

May 09, 2025

Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

May 09, 2025

Sight Sciences, Inc. Earnings Call: Mixed Results and Strategic Focus - TipRanks

May 09, 2025

Earnings call transcript: Sight Sciences misses Q1 2025 EPS forecast, stock rises - Investing.com Nigeria

May 09, 2025

Sight Sciences stock holds as Needham reiterates rating By Investing.com - Investing.com Nigeria

May 09, 2025

Sight Sciences stock holds as Needham reiterates rating - Investing.com

May 09, 2025

Sight Sciences: Balancing Resilience and Caution Amid Tariff Challenges - TipRanks

May 09, 2025

Sight Sciences (SGHT): Analyst Raises Price Target Despite Hold Rating | SGHT Stock News - GuruFocus

May 09, 2025